Skip to main content
. Author manuscript; available in PMC: 2022 Jan 24.
Published in final edited form as: Eur J Cancer. 2019 Jun 15;116:199–206. doi: 10.1016/j.ejca.2019.05.005

Table 2.

Parity as an independent risk factor for breast cancer in women with Li-Fraumeni syndrome due to known germline TP53 variants

Parameter Number of
women without
breast cancer
Number of
women with
breast cancer
Hazard
Ratio
95%CI p-value
Effect of parity on breast cancer risk (all women)
Nulliparous 34 33 -
Parous 33 52 1.07 (0.66, 1.77) 0.8
Effect of parity on breast cancer risk stratified by age at study entry
≤ 40 years
Nulliparous 43 30 -
Parous 43 34 1. 12 (0.66,1.91) 0.7
>40 years
Nulliparous 4 3 -
Parous 21 11 0.85 (0.24,3.07) 0.8
Number of live births
Nulliparous 37 30 -
1 5 13 1.23 (0.69,2.19) 0.5
2 16 32 1.13 (0.61,2.09) 0.7
3 5 6 0.82 (0.31,2.20) 0.7
4+ 5 3 0.29 (0.04,2.12) 0.23
Per live birth 0.93 (0.76,1.14) 0.5
Age at first live birth (years)
Nulliparous 33 33 -
<25 23 16 0.71 (0.38,1.41) 0.29
25–29 7 21 1.44 (0.83,2.97) 0.26
≥30 5 14 2.14 (1.1,5.24) 0.05

Parous= at least one liveborn child